$ACH

ACCENDRA HEALTH INC/VA/ (ACH): Entry into a Material Definitive Agreement

ACCENDRA HEALTH INC/VA/ (ACH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-4.1 3 tm2622667d3_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 SECTION 382 RIGHTS AGREEMENT Dated as of August 10, 2026 between ACCENDRA HEALTH, INC. and Computershare TRUST COMPANY, N.A. , as Rights Agent TABLE OF CONTENTS Page Section 1. Definitions 1 Section 2. Appointment of Rights A

Original reporting
Published Aug 10, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ACH
Neutral
medium confidence
Mentioned
$ACH
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ACHNeutralMed
01

Why it matters

By setting an “Acquiring Person” threshold at 4.9% beneficial ownership, the plan is intended to preserve NOLs or other tax attributes under IRC Section 382/383, potentially influencing takeover risk and activist behavior.

02

Market read

This is a defensive corporate action that can matter for event-driven traders focused on ownership-change risk, but it does not provide new operating or financial metrics.

03

What to watch

Traders may need to monitor any future ownership accumulation near the 4.9% threshold, since the agreement is designed to trigger protective mechanisms around that level.

Relevance 6/10Novelty 6/10Timing: filed Aug. 10, 2026, after-hours/late session disclosure

Background

The 8-K reports entry into a Section 382 rights agreement with Computershare as rights agent, aiming to avoid an ownership change that would impair US federal tax attributes.

Company-level read

Ticker impact

$ACHNeutralMedium confidence
Context

Accendra Health filed an 8-K disclosing a Section 382 rights agreement to preserve tax attributes by deterring ownership changes above 4.9%.

Expected impact

Near-term impact likely limited, but the plan can reduce probability of an ownership-change event and may modestly affect takeover premium expectations.

Evidence & confidence

The filing is a primary disclosure of a new Section 382 rights agreement, but it does not include financial guidance, deal terms, or operational changes.

Market effects

Rights plans for tax-attribute preservation can be a recurring theme for small-cap issuers with NOLs, but this is company-specific.

No clear regional spillover indicated.

No global market linkage indicated.

Counterpoint

The plan may be largely procedural for tax planning, with limited incremental information about business fundamentals.

Key entities

  • Accendra Health, Inc.

    Subject of the 8-K and the Section 382 rights agreement.

  • Computershare Trust Company, N.A.

    Appointed as rights agent under the agreement.

Related articles

$ACHHighAI 8/10

Accendra Health (ACH) Q2 2026 Earnings Call Transcript

Accendra Health (ACH) reported Q2 2026 revenue of $613.2M, down from $681.9M YoY, and adjusted EBITDA of $60.1M, down from $96.6M. The company revised full-year revenue guidance to $2.45B-$2.55B and adjusted EBITDA to $300M-$320M, citing slower growth and collection rate issues. Total debt decreased by $385M to $1.72B. CEO Edward Pesicka announced his retirement by year-end.

$ACHMedAI 8/10

Accendra Health (ACH) Q2 2026 Earnings Call Transcript

Accendra Health (ACH) reported Q2 2026 net revenue of $613.2 million, down from $681.9 million a year earlier, and adjusted EBITDA of $60.1 million versus $96.6 million. Full-year revenue guidance was revised to $2.45 billion to $2.55 billion and adjusted EBITDA to $300 million to $320 million. Debt fell to $1.72 billion as of June 30, 2026.

$ACHMedAI 8/10

Accendra Health Reports Lower Q2 Revenue, Sets 2026 Guidance; Adopts Tax Asset Plan; Stock Down

Accendra Health (ACH) reported Q2 2026 revenue of $613.2 million, down from $681.9 million a year earlier, with GAAP net loss of $89.1 million ($1.16/share). Non-GAAP adjusted net loss was $14.3 million. Adjusted EBITDA fell to $60.1 million and free cash flow was -$25.1 million. The company guided FY2026 revenue $2.45-$2.55 billion and adjusted EBITDA $300-$320 million, and adopted a tax asset preservation plan.

$ACHMed

ACCENDRA HEALTH INC/VA/ (ACH): Results of Operations and Financial Condition

ACCENDRA HEALTH INC/VA/ (ACH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622667d2_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Accendra Health Reports Second Quarter 2026 Financial Results Reduced Total Debt By $385 Million In Second Quarter CEO Ed Pesicka Announces Intention To Retire By The End of 2026 RICHMOND, VA – August 10, 2026 – Accendra

$ACHMed

Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds

Accendra Health Inc. (NYSE:ACH) said on June 23 it completed exchange offers for its 4.5% senior notes due 2029 and 6.625% senior notes due 2030. The notes were exchanged for new 9% senior secured first-lien notes due 2032 and 9.75% senior secured second-lien notes due 2033. Accendra expects to issue about $539.25 million first-lien notes and about $698.1 million second-lien notes, while S&P Global Ratings affirmed a 'B' issuer rating and moved outlook to stable.

$BABAHighAI 9/10

Alibaba’s $10.2B Hong Kong Share Sale Excluded US Holders From Discount: Insiders Bought Anyway

Alibaba raised $10.2B in Hong Kong's largest-ever primary follow-on share offering, pricing 710M shares at an 8.4% discount. US investors were excluded due to regulatory restrictions. Shares fell up to 10% post-offering, with insiders like Chairman Joe Tsai and CEO Eddie Wu buying shares, signaling confidence. Proceeds will fund AI, cloud, and chip investments. According to Alibaba, the company's AI strategy aims to enhance its full-stack capabilities.